IMPROVING THE DIAGNOSIS AND ORGANIZATION OF MEDICAL CARE FOR CHILDREN WITH ACUTE RESPIRATORY INFECTIONS (ARIS)
Mirkhoshimov Mirbobir
The Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases
Keywords: Acute respiratory infections, pediatric diagnostics, clinical protocols, child healthcare, viral infections, medical organization, evidence-based medicine
Abstract
Acute respiratory infections (ARIs) are among the leading causes of morbidity and hospitalization in pediatric populations worldwide. These conditions encompass a broad spectrum of viral and bacterial pathogens that affect the upper and lower respiratory tracts and often present with overlapping clinical symptoms, complicating timely diagnosis and appropriate therapeutic intervention. Inadequate early identification of the etiological agent frequently leads to overuse of antibiotics, delayed treatment, and increased healthcare burden. The optimization of diagnostic protocols—particularly in outpatient pediatric practice—combined with the development of integrated approaches to the organization of medical care, is essential for reducing disease severity, preventing complications, and improving outcomes. This article examines current challenges in the diagnosis of ARIs in children, evaluates existing clinical practices, and offers evidence-based recommendations for enhancing both diagnostic accuracy and the provision of medical care.
References
1. World Health Organization. (2013). Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. 2nd ed. Geneva: WHO.
2. Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J. E., ... & Black, R. E. (2015). Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. The Lancet, 385(9966), 430–440. https://doi.org/10.1016/S0140-6736(14)61698-6
3. Esposito, S., & Principi, N. (2012). Unsolved problems in the approach to pediatric community-acquired pneumonia. Current Opinion in Infectious Diseases, 25(3), 286–291. https://doi.org/10.1097/QCO.0b013e3283536d8e
4. Ginsburg, A. S., & Klugman, K. P. (2017). Vaccination to reduce antimicrobial resistance. The Lancet Global Health, 5(12), e1176–e1177. https://doi.org/10.1016/S2214-109X(17)30476-2
5. Greenberg, D., Givon-Lavi, N., Sadaka, Y., Ben-Shimol, S., Bar-Ziv, J., Dagan, R. (2014). Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. The Lancet, 385(9979), 1729–1737. https://doi.org/10.1016/S0140-6736(14)61086-6
6. McCullers, J. A. (2006). Insights into the interaction between influenza virus and pneumococcus. Clinical Microbiology Reviews, 19(3), 571–582. https://doi.org/10.1128/CMR.00058-05
7. Zar, H. J., & Ferkol, T. W. (2014). The global burden of respiratory disease—impact on child health. Pediatric Pulmonology, 49(5), 430–434. https://doi.org/10.1002/ppul.23030
8. Don, M., Valent, F., Korppi, M., Canciani, M. (2007). Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatric International, 51(1), 91–96. https://doi.org/10.1111/j.1442-200X.2008.02501.x
9. Jain, S., Williams, D. J., Arnold, S. R., Ampofo, K., Bramley, A. M., Reed, C., ... & Finelli, L. (2015). Community-acquired pneumonia requiring hospitalization among U.S. children. New England Journal of Medicine, 372(9), 835–845. https://doi.org/10.1056/NEJMoa1405870
10. Alverson, B. K., & Halasa, N. B. (2019). Diagnostic testing in children with respiratory tract infections. Pediatric Clinics of North America, 66(4), 697–710. https://doi.org/10.1016/j.pcl.2019.03.001














